AMA expands CPT codes for SSKN's XTRAC laser; now covers vitiligo, atopic dermatitis, alopecia

STRATA Skin Sciences, Inc.

AMA CPT Editorial Panel revised codes 96920-96922 to include inflammatory/autoimmune skin diseases beyond psoriasis.
Expanded coverage unlocks up to 30M potential patients (vs. 10M psoriasis-only), including 3M vitiligo, 16.5M atopic dermatitis patients.
Expected to reduce systemic denials and prior authorizations; non-psoriasis treatments were ~30% of 2023 Medicare volume.
CEO Dr. Rafaeli calls it an 'inflection point' for XTRAC; company expects accelerated revenue growth and broader clinic adoption.
STRATA collaborated with leading dermatologists (Dr. Lebwohl, Dr. Grimes, Dr. Richard) on the CPT change application.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.